Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Apr;12(4):386-391.
doi: 10.1136/neurintsurg-2019-015215. Epub 2019 Aug 30.

First pass effect with contact aspiration and stent retrievers in the Aspiration versus Stent Retriever (ASTER) trial

Collaborators, Affiliations
Randomized Controlled Trial

First pass effect with contact aspiration and stent retrievers in the Aspiration versus Stent Retriever (ASTER) trial

Célina Ducroux et al. J Neurointerv Surg. 2020 Apr.

Abstract

Background: The 'first pass effect' (FPE), which was originally described with stent retrievers, designates a (near-)complete revascularization obtained after a single device pass with no rescue therapy, and is associated with improved clinical outcome and decreased mortality.

Objective: We report the rate and benefits of FPE in the Aspiration versus Stent Retriever (ASTER) trial.

Materials and methods: ASTER is a randomized trial comparing angiographic revascularization with the stent retriever (SR) and contact aspiration (CA) thrombectomy techniques, assessed by an external core laboratory using the modified Thrombolysis in Cerebral Infarction (mTICI) scale. Rates of FPE (defined by mTICI 2c/3 after a single pass with no rescue therapy) were compared between patients treated with SR and CA techniques. Outcomes were compared between FPE-SR and FPE-CA patients, and between FPE and non-FPE patients.

Results: FPE was achieved in 97/336 patients (28.9%), with no significant difference between SR and CA (respectively 53/169 patients (31.3%) vs 44/167 patients (26.3%), adjusted RR for CA versus SR 0.84, 95% CI 0.54 to 1.31; p=0.44). After prespecified adjustment for allocated arm and randomization stratification factors, FPE in patients was associated with a significantly improved clinical outcome and a decreased mortality, and a significantly lower rate of hemorrhagic transformation and procedural complications than in non-FPE patients.

Conclusion: In the ASTER trial, similar rates of FPE were achieved with SR and CA, and FPE was associated with a significantly improved outcome. New techniques and devices to improve the rate of FPE are warranted.

Trial registration number: Unique identifier: NCT02523261.

Keywords: recanalization; stroke; thrombectomy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study flow chart. CA, contact aspiration; SR, stent retriever
Figure 2
Figure 2
Distribution of modified Rankin Scale scores at 90 Days according to first pass effect in the ASTER trial. cOR was calculated for one-point improvement in the modified Rankin Scale score using a mixed ordinal logistic regression model including center as random effect and first-line mechanical thrombectomy strategy and intravenous recombinant tissue plasminogen activator as fixed effects. cOR, common odds ratio; FPE, first pass effect.

References

    1. Leslie-Mazwi T, Chandra RV, Baxter BW, et al. ELVO: an operational definition. J Neurointerv Surg 2018;10:507–9. 10.1136/neurintsurg-2018-013792 - DOI - PubMed
    1. Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 2013;44:2650–63. 10.1161/STROKEAHA.113.001972 - DOI - PMC - PubMed
    1. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–110. 10.1161/STR.0000000000000158 - DOI - PubMed
    1. Leslie-Mazwi T, Chandra RV, Fraser JF, et al. AHA/ASA 2018 AIS guidelines: impact and opportunity for endovascular stroke care. J Neurointerv Surg 2018;10:817–7. 10.1136/neurintsurg-2018-013911 - DOI - PubMed
    1. Mocco J, Fiorella D, Fargen KM, et al. Endovascular therapy for acute ischemic stroke is indicated and evidence based: a position statement. J Neurointerv Surg 2015;7:79–81. 10.1136/neurintsurg-2014-011591 - DOI - PubMed

Publication types

Associated data